@drkethu: A new hepatitis B treatment could help some patients eventually stop long-term antiviral medication. The FDA has approved bepirovirsen, a new drug that targets hepatitis B RNA and can reduce hepatitis B surface antigen. In studies, some patients achieved what doctors call a functional cure after treatment. This is not for everyone with hepatitis B, and it requires close monitoring, but it is a major step toward finite treatment instead of lifelong therapy for selected patients. Do not stop your current hepatitis B medication without talking to your doctor. #HepatitisB #LiverHealth #HBV #Hepatology #MedicalNews

Dr. Kethu, MD, FACG.

Open In TikTok:

Region: US

Thursday 22 October 2026 16:00:00 GMT